Pasquel, F.J., Gianchandani, R., Rubin, D.J., et al. (2017) Efficacy of Sitagliptin for the Hospital Management of General Medicine and Surgery Patients with Type 2 Diabetes (Sita-Hospital): A Multicentre, Prospective, Open-Label, Non-Inferiority Randomised Trial. The Lancet Diabetes & Endocrinology, 5, 125-133.
https://doi.org/10.1016/S2213-8587(16)30402-8

has been cited by the following article:

• TITLE: Proposed Libyan Guidelines for the Management of Inpatient Hyperglycemia with Corona Virus-19 (COVID-19) Infection

  AUTHORS: Adela H. Elamami

  KEYWORDS: In-Patient Hyperglycemia, COVID-19, Management, Proposed Guideline, Libya

  JOURNAL NAME: Open Journal of Epidemiology, Vol.11 No.3, July 23, 2021

  ABSTRACT: Serious hyperglycemia is one of the manifestations of COVID-19 infection which increase patient morbidity and mortality especially in patient requiring hospitalization. Consequently, many protocols and algorithms for hospitalized patients with COVID-19 induced hyperglycemia based mainly on recent studies and previous evidence on non-COVID-19 patients were published. Of note nearly all guidelines released by the different COVID-19 committees in Libya don’t include a clear focus on management of in-patient hyperglycemia and maybe this plays a pivotal role in increase our COVID-19 in-hospital mortality. I proposed a simplified approach depending on the released international guidelines to be easily implemented by Libyan health care staff caring about COVID-19 patients and hoping to be accepted by our National Diabetes Committee.